The European Union has achieved near-universal health coverage (Mean=99.15%; Standard Deviation=1.46%; Variation Coefficient=1%) and equity of access to healthcare services but, in the period 2000-10, such goal has been achieved at a Not Sustainable rate with total health expenditure growth (4.2%, STDDEV=2.4%) exceeding the growth rate of the GDP (1.7%,STDDEV=1.4%) by +2.5 percentage points on average and pharmaceutical expenditure (3.5%, STDDEV=3.0%) exceeding the growth rate of the GDP by +1.8 points. In the period 2011-2060 the GDP is expected to reduce and stabilize its growth rate from an average of 1.7% (STDDEV=1.4%) to an average of 1.6% with lower variation among the countries of the EU (STDDEV=0.5%). There follows that if the growth rate of health and pharmaceutical expenditure of the period 2000-10 is not reduced in the period 2011-60 only 4 nations will achieve economic and financial sustainability: Netherlands, Sweden, Denmark and Italy. Health policymakers in the European Union should account for this long-term expenditure growth pattern and reform in the efficiency and effectiveness of health and pharmaceutical care is necessary if health outcomes are to be improved and at the same time the economic and financial sustainability of the European universal welfare model is to be preserved and inequality avoided.

Long-term financial sustainability and inequalty of pharmaceutical expenditure in the European Union, 2011-2060: a comparative analysis

DANOVI, Alessandro;
2013-01-01

Abstract

The European Union has achieved near-universal health coverage (Mean=99.15%; Standard Deviation=1.46%; Variation Coefficient=1%) and equity of access to healthcare services but, in the period 2000-10, such goal has been achieved at a Not Sustainable rate with total health expenditure growth (4.2%, STDDEV=2.4%) exceeding the growth rate of the GDP (1.7%,STDDEV=1.4%) by +2.5 percentage points on average and pharmaceutical expenditure (3.5%, STDDEV=3.0%) exceeding the growth rate of the GDP by +1.8 points. In the period 2011-2060 the GDP is expected to reduce and stabilize its growth rate from an average of 1.7% (STDDEV=1.4%) to an average of 1.6% with lower variation among the countries of the EU (STDDEV=0.5%). There follows that if the growth rate of health and pharmaceutical expenditure of the period 2000-10 is not reduced in the period 2011-60 only 4 nations will achieve economic and financial sustainability: Netherlands, Sweden, Denmark and Italy. Health policymakers in the European Union should account for this long-term expenditure growth pattern and reform in the efficiency and effectiveness of health and pharmaceutical care is necessary if health outcomes are to be improved and at the same time the economic and financial sustainability of the European universal welfare model is to be preserved and inequality avoided.
journal article - articolo
2013
Danovi, Alessandro; Olgiati, Stefano
File allegato/i alla scheda:
File Dimensione del file Formato  
financial sustainability-Danovi_Olgiati.pdf

accesso aperto

Descrizione: publisher's version - versione dell'editore
Dimensione del file 188.35 kB
Formato Adobe PDF
188.35 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Aisberg ©2008 Servizi bibliotecari, Università degli studi di Bergamo | Terms of use/Condizioni di utilizzo

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10446/30283
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact